Taiwan Design Research Institute (TDRI) cooperates with New Taipei City Department of Health for the “Public Health Center Re-Designed” project, hoping to make use of design to turn the image and service efficiency of public health institutions around. In Taiwan, the KPI of every public health center is to complete 300 services a year. TDRI first launches demo projects at Xizhi District Public Health Center and Yingge District Public Health Center that service large populations, in which TDRI conducts preliminary service design research and then hands over to local design teams “S. Select Lab” and “Zuo Studio” for overall visual and spatial planning.
Throughout the course of life from birth to death, which place is the most closely related to our daily life? It is not some popular trendy cafés or Michelin-starred restaurants with long queues, but the often overlooked public health centers in our neighborhoods. From vaccinations for infants, health education for newlyweds, to regular checkups for elderly citizens, all these are conducted in public health centers.
However, when people think of those public health centers near home, they often give the impression of being old, dim, with walls full of health education posters; with unclear signs and instructions and bad traffic flow design, citizens all squeeze in front of the registration counter, and staff members and volunteers are exhausted answering their questions. Consequently, there is a long queue for every service, affecting the service efficiency and capacity of public health center. Moreover, with the rise of preventive healthcare in recent years, and growing demand of elderly care, all public health centers across Taiwan are seeing growing workloads, further straining public health centers’ utilization effectiveness and spatial affordance.
The design planning focuses on a number of key areas. First, color scheme. In the past, public health centers had no consistent colors, whereas now, neutral and natural earth tones have been used to recolor the space into beige, grey, and khaki, while also defining the waiting areas, consulting rooms, and independent spaces (such as health education rooms and counseling rooms). Senior-friendly desks and chairs that can be easily moved around are also used to give the overall space consistency, and inject a sense of warmth and peace of mind.
Second, service design. Traffic flow is reexamined. Through design, people are evenly distributed to all areas, and the overall service flow is expedited. The final and most-important area is modular design. Modularized walls are used in combination with signage design and furniture that can be freely adjusted to create a space that is vaccination room in the morning and health education room in the afternoon, meeting health public centers’ demand for versatility and flexibility.
Furthermore, modularization is also applied for spatial replicability. TDRI hopes that this project can set a new paradigm for the future. This demo project can be flexibly replicated to over 350 public health centers across Taiwan, or even overseas. This project is not just a project of public service design, but also a paradigm of interdepartmental cooperation, offering countries around the world that are in dire need for improved public health service efficiency a quick and effective solution.
SOURCE Taiwan Design Research Institute
Taiwan Main Orthopaedic Biotechnology announced today (12) that their OOOPDS 3D medical image reconstruction and surgical planning medical software has received TFDA Class-II certification. OOOPDS is the most comprehensive 3D surgical planning software in Taiwan. It is easy to combine medical-grade 3D printers. The next step is to submit for the USFDA to enter the US and worldwide 3D medical printing markets.
In recent years, 3D printing technology has gradually matured and has been applied in various related medical fields such as orthopedics, spine, dentistry, etc. However, the certified 3D medical imaging surgical planning is the key point that the printed 3D materials transfer into actual medical products. There is very few software like OOOPDS that offered easy-to-use functions the support not only the ultrafast conversion of DICOM into accurate 3D objects but also the one-touch segmentation for the surgical planning to simulate the surgical outcome. It is compatible to connect with 3D printers to print medical implants including metallic materials.
Patient-specific implants using 3D printers have proved their advantages in many research papers in recent decades. Using the patient’s CT and MRI scans to convert into doctors’ surgical plans and through 3D printing to generate custom implants is the best solution for implants. The main part is a key certificated medical software for the applications. OOOPDS is now ready to go into the market with TFDA in Taiwan. For more information, please refer to our official website on www.surglasses.com.
The CEO Wang Min-Liang said Taiwan Main Orthopaedic Biotechnology is well-known innovative medical device company that developed the world’s first smart surgical glasses with Augmented Reality technology. Our smart surgical glasses products obtained the CE mark, and the product has been deployed in the UK, Europe, the Middle East, India, Russia, and other regions. The company is very innovative when it comes to medical software and algorithms. The OOOPDS software is one of our key projects while the company startup. We are very happy to announce the TFDA certification for OOOPDS and we welcome any kind of cooperation.
Keywords: 3D medical software, 3D orthopedics printing, 3D printing medical, medical 3D reconstruction
SOURCE Taiwan Main Orthopaedic Biotechnology Co., Ltd.
– World’s first BNCT systems as medical device –
Sumitomo Heavy Industries, Ltd. (TOKYO:6302)(President: Shinji Shimomura, referred as SHI hereinafter) has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an accelerator (cyclotron), targeting carcinoma of the head and neck region in collaboration with STELLA PHARMA CORPORATION (President: Tomoyuki Asano). And SHI has applied the system for new medical device approval on 11th October, 2019. Today, we would like to announce that Sumitomo Heavy Industries, Ltd. obtains new medical device approval for manufacturing and sales of accelerator based BNCT system (NeuCureTM System) and the dose calculation program (NeuCureTM Dose Engine) from Japanese Ministry of Health, Labor and Welfare. These are the world’s first medical devices for BNCT.
Market and SHI’s target
BNCT is unique radiation therapy method which is led by Japanese researchers. SHI believes better treatment will be provided to patients in the world. Once STELLA PHARMA CORPORATION obtains the drug application approval, SHI would like to develop BNCT market globally together with partners by means of sending information of BNCT and the clinical outcome to the world. It may take years for obtaining global common recognition. However, SHI would like to install more than 100 systems globally as a long term target. SHI will keep making efforts to improve and develop NeuCureTM system and NeuCureTM Dose Engine.